Matrixyl vs Palmitoyl Pentapeptide-4 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Matrixyl is the trade name for Palmitoyl Pentapeptide-4 (Pal-KTTKS), developed by Sederma (now Croda). It is derived from a procollagen type I C-terminal propeptide fragment and uses palmitoylation to cross the skin lipid barrier and reach dermal fibroblasts....
Calculate Matrixyl dose →Palmitoyl Pentapeptide-4 (Pal-KTTKS, also marketed as Matrixyl) is a cosmetic peptide derived from a fragment of procollagen type I. The palmitoyl fatty acid attachment allows it to penetrate the skin lipid barrier and reach dermal fibroblasts....
Calculate Palmitoyl Pentapeptide-4 dose →| Parameter | Matrixyl | Palmitoyl Pentapeptide-4 |
|---|---|---|
| Category | Skin & Cosmetic | Skin & Cosmetic |
| Research | Widely Used (Cosmetic) | Widely Used (Cosmetic) |
| Half-Life | - | - |
| Typical Dose | 3–5% in formulation | 3–5% in formulation |
| Frequency | Twice daily | Once or twice daily |
| Route | Topical | Topical |
| FDA Status | Not Approved (Cosmetic) | Not Approved (Cosmetic Ingredient) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.